Markers of inflammation and fat distribution following weight loss in African-American and white women

Obesity

Volumn 20, Issue 4, 2012, Pages 715-720

  Fisher, Gordon ^a   Hyatt, Tanya C ^a   Hunter, Gary R ^a   Oster, Robert A ^b   Desmond, Renee A ^b   Gower, Barbara A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b and Clinical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOSE TISSUE; ADULT; AFRICAN AMERICAN; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC DIFFERENCE; EXERCISE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADULT; AFRICAN AMERICANS; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84859210153     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.85     Document Type: Article

References (34)

1. Guh DP, Zhang W, Bansback N et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88.
2. Robbie L, Libby P. Inflammation and atherothrombosis. Ann N Y Acad Sci 2001;947:167-179; discussion 179.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-867. (Pubitemid 36019639)
4. Akiyama H, Barger S, Barnum S et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421. (Pubitemid 30349107)
5. Katzmarzyk PT, Bray GA, Greenway FL et al. Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr 2010;91:7-15.
6. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-2698. (Pubitemid 34615135)
7. Gower BA, Ard JD, Hunter GR, Fernandez J, Ovalle F. Elements of the metabolic syndrome: association with insulin sensitivity and effects of ethnicity. Metab Syndr Relat Disord 2007;5:77-86. (Pubitemid 46641425)
8. Osei K, Schuster DP. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med 1994;11:755-762. (Pubitemid 24319774)
9. Minor DS, Wofford MR, Jones DW. Racial and ethnic differences in hypertension. Curr Atheroscler Rep 2008;10:121-127. (Pubitemid 351486146)
10. Festa A, D'Agostino R Jr, Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47. (Pubitemid 30430551)
11. Winkler G, Kiss S, Keszthelyi L et al. Expression of tumor necrosis factor (TNF)-protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-?, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 2003;149:129-135. (Pubitemid 36987155)
12. Hyatt TC, Phadke RP, Hunter GR et al. Insulin sensitivity in African-American and white women: association with inflammation. Obesity (Silver Spring) 2009;17:276-282.
13. Giugliano G, Nicoletti G, Grella E et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 2004;57:190-194. (Pubitemid 38380434)
14. Klein S, Fontana L, Young VL et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350:2549-2557. (Pubitemid 38758542)
15. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem 2004;50:574-581. (Pubitemid 38297308)
16. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004;93:1238-1242. (Pubitemid 38595677)
17. Patel DA, Srinivasan SR, Xu JH et al. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metab Clin Exp 2006;55:699-705.
18. Carroll JF, Fulda KG, Chiapa AL et al. Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring) 2009;17:1420-1427.
19. Heald AH, Anderson SG, Ivison F et al. C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 2003;170:79-86. (Pubitemid 37083566)
20. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-809. (Pubitemid 34174919)
21. Marfella R, Esposito K, Siniscalchi M et al. Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 2004;27:47-52. (Pubitemid 38196708)
22. Nicklas BJ, Ambrosius W, Messier SP et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 2004;79:544-551. (Pubitemid 41103895)
23. Kekes-Szabo T, Hunter GR, Nyikos I et al. Development and validation of computed tomography derived anthropometric regression equations for estimating abdominal adipose tissue distribution. Obes Res 1994;2: 450-457.
24. Goran MI, Kaskoun M, Shuman WP. Intra-abdominal adipose tissue in young children. Int J Obes Relat Metab Disord 1995;19:279-283.
25. Smith SR, Lovejoy JC, Greenway F et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metab Clin Exp 2001;50:425-435. (Pubitemid 32321951)
26. Straczkowski M, Kowalska I, Nikolajuk A et al. Plasma levels of soluble tumor necrosis factor-receptors are related to total and LDL-cholesterol in lean, but not in obese subjects. Cardiovasc Diabetol 2006;5:14.
27. Diez-Ruiz A, Tilz GP, Zangerle R et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
28. Liang H, Yin B, Zhang H et al. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-signaling protected Wistar rats from dietinduced obesity and insulin resistance. Endocrinology 2008;149:2943-2951. (Pubitemid 351724499)
29. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997;46:451-455. (Pubitemid 27090275)
30. Fernández-Real JM, Broch M, Ricart W et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998;47:1757-1762. (Pubitemid 28476250)
31. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-and soluble TNF-receptors in obesity. Int J Obes Relat Metab Disord 2000;24:1392-1395.
32. Bastard JP, Jardel C, Bruckert E, Vidal H, Hainque B. Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obes Metab 2000;2:323-325. (Pubitemid 33072202)
33. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-214. (Pubitemid 30064452)
34. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-1013. (Pubitemid 46525079)